Tego Science

191420 · KOSDAQ · Health Care · SMALL CAP

An acquisition.

Tego Science disclosed an acquisition of P&P Pharm Co., Ltd., worth US$2.48M.

M&A(Decision to acquire shares/equity in another company (voluntary))· FILED 2026-05-19· RCEPT 20260519900228

US$2.48MDeal value
4.8%vs. company assets

Converted at 1 USD ≈ ₩1,507.85 (filing-date rate, 2026-05-19 close)

What happened

Tego Science disclosed an acquisition of P&P Pharm Co., Ltd., worth US$2.48M.

For context, this deal is worth about 4.8% of the company's own total assets.

TargetP&P Pharm Co., Ltd.
Deal valueUS$2.48M
vs. company assets4.8%
Filed2026-05-19, Decision to acquire shares/equity in another company (voluntary)
SourceDART rcept 20260519900228 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-19 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.